It is unclear if latent cognitive profiles can distinguish between dementia with subcortical vascular lesions and Alzheimer’s disease (AD) at the incipient stage, and if they differ in performance from the Petersen subtypes.
Objective:
To identify latent cognitive profiles in a naturalistic population of patients from a memory clinic sample, and investigate the derived classes not only in terms of conversion to AD, but also in terms of conversion to dementia with subcortical vascular lesions. Another objective was to compare the derived classes to the Petersen subtypes.
Methods:
We performed a latent profile analysis (LPA) on standardized neuropsychological test scores from 476 memory clinic patients (age 64±8) without dementia, and analyzed progression to dementia after 2 years.
Results:
The LPA resulted in two classes with impaired cognition (Amnestic and Slow/Dysexecutive) and two classes with normal cognition (Normal-Low and Normal-High cognition). Belonging to the Amnestic class predicted progression to all-cause dementia and to AD; belonging to the Slow/Dysexecutive class predicted progression to all-cause dementia, AD, and dementia with subcortical vascular lesions. Of the Petersen MCI subtypes, only amnestic multi-domain MCI predicted progression to all-cause dementia, AD, and dementia with subcortical vascular lesions.
Conclusion:
Latent cognitive profiles separated between AD and dementia with subcortical vascular lesions, while the Petersen subtypes did not. However, similar to the Petersen subtypes, LPA classes work better for ruling out progression to dementia than for case finding.
GothlinM, EckerstromM, RolstadS, KettunenP, WallinA (2018) Better prognostic accuracy in younger mild cognitive impairment patients with more years of education. Alzheimers Dement10, 402–412.
2.
GothlinM, EckerstromM, RolstadS, WallinA, NordlundA (2017) Prognostic accuracy of mild cognitive impairment subtypes at different cut-off levels. Dement Geriatr Cogn Disord43, 330–341.
3.
PetersenRC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med256, 183–194.
Delano-WoodL, BondiMW, SaccoJ, AbelesN, JakAJ, LibonDJ, BozokiA (2009) Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology. J Int Neuropsychol Soc15, 906–914.
9.
EdmondsEC, Delano-WoodL, ClarkLR, JakAJ, NationDA, McDonaldCR, LibonDJ, AuR, GalaskoD, SalmonDP, BondiMW, Alzheimer’s Disease Neuroimaging Initiative (2015) Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement11, 415–424.
10.
LibonDJ, XieSX, EppigJ, WicasG, LamarM, LippaC, BettcherBM, PriceCC, GiovannettiT, SwensonR, WambachDM (2010) The heterogeneity of mild cognitive impairment: a neuropsychological analysis. J Int Neuropsychol Soc16, 84–93.
11.
PastorDA, BarronKE, MillerBJ, DavisSL (2007) A latent profile analysis of college students’ achievement goal orientation. Contemp Educ Psychol32, 8–47.
12.
BerlinKS, WilliamsNA, ParraGR (2014) An introduction to latent variable mixture modeling (part 1): overview and cross-sectional latent class and latent profile analyses. J Pediatr Psychol39, 174–187.
13.
MagidsonJ, VermuntJ (2002) Latent class models for clustering: A comparison with K-means. Can J Mark Res20, 36–43.
14.
MuthénB (2004) Latent variable analysis: growth mixture modeling and related techniques for longitudinal data. In The SAGE Handbook of Quantitative Methodology for the Social Sciences, KaplanD, ed. SAGE Publications, Inc.
15.
RoeschSC, VillodasM, VillodasF (2010) Latent class/profile analysis in maltreatment research: a commentary on Nooner et al., Pears et al., and looking beyond. Child Abuse Negl34, 155–160.
16.
KohlerS, HamelR, SistermansN, KoeneT, PijnenburgYA, van der FlierWM, ScheltensP, VisserPJ, AaltenP, VerheyFR, RamakersI (2013) Progression to dementia in memory clinic patients without dementia: a latent profile analysis. Neurology81, 1342–1349.
17.
McGuinnessB, BarrettSL, McIlvennaJ, PassmoreAP, ShorterGW (2015) Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping. Alzheimers Dement1, 447–454.
18.
EppigJS, EdmondsEC, CampbellL, Sanderson-CiminoM, Delano-WoodL, BondiMW, Alzheimer’s Disease Neuroimaging Initiative (2017) Statistically derived subtypes and associations with cerebrospinal fluid and genetic biomarkers in mild cognitive impairment: a latent profile analysis. J Int Neuropsychol Soc23, 564–576.
19.
HanfeltJJ, WuuJ, SollingerAB, GreenawayMC, LahJJ, LeveyAI, GoldsteinFC (2011) An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer’s Coordinating Center. Am J Geriatr Psychiatry19, 940–950.
20.
RizziL, RossetI, Roriz-CruzM (2014) Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int2014, 908915.
21.
GorelickPB, ScuteriA, BlackSE, DecarliC, GreenbergSM, IadecolaC, LaunerLJ, LaurentS, LopezOL, NyenhuisD, PetersenRC, SchneiderJA, TzourioC, ArnettDK, BennettDA, ChuiHC, HigashidaRT, LindquistR, NilssonPM, RomanGC, SellkeFW, SeshadriS, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke42, 2672–2713.
22.
WallinA, NordlundA, JonssonM, LindK, EdmanA, GothlinM, StalhammarJ, EckerstromM, KernS, Borjesson-HansonA, CarlssonM, OlssonE, ZetterbergH, BlennowK, SvenssonJ, OhrfeltA, BjerkeM, RolstadS, EckerstromC (2016) The Gothenburg MCI study: Design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up. J Cereb Blood Flow Metab36, 114–131.
23.
WallinA, NordlundA, JonssonM, BlennowK, ZetterbergH, OhrfeltA, StalhammarJ, EckerstromM, CarlssonM, OlssonE, GothlinM, SvenssonJ, RolstadS, EckerstromC, BjerkeM (2016) Alzheimer’s disease–subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies. J Cereb Blood Flow Metab36, 95–113.
24.
GeffenGM, ButterworthP, GeffenLB (1994) Test-retest reliability of a new form of the auditory verbal learning test (AVLT). Arch Clin Neuropsychol9, 303–316.
25.
CrossleyM, D’ArcyC, RawsonNS (1997) Letter and category fluency in community-dwelling Canadian seniors: a comparison of normal participants to those with dementia of the Alzheimer or vascular type. J Clin Exp Neuropsychol19, 52–62.
26.
ReitanR (1985) The Halstead-Reitan Neuropsychological Test Battery, Neuropsychology Press, Tucson.
BinettiG, CappaSF, MagniE, PadovaniA, BianchettiA, TrabucchiM (1998) Visual and spatial perception in the early phase of Alzheimer’s disease. Neuropsychology12, 29–33.
29.
NordlundA, RolstadS, HellstromP, SjogrenM, HansenS, WallinA (2005) The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry76, 1485–1490.
30.
MattssonN, ZetterbergH, HanssonO, AndreasenN, ParnettiL, JonssonM, HerukkaSK, van der FlierWM, BlankensteinMA, EwersM, RichK, KaiserE, VerbeekM, TsolakiM, MulugetaE, RosenE, AarslandD, VisserPJ, SchroderJ, MarcussonJ, de LeonM, HampelH, ScheltensP, PirttilaT, WallinA, JonhagenME, MinthonL, WinbladB, BlennowK (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA302, 385–393.
31.
ReisbergB, FerrisSH, de LeonMJ, CrookT (1988) Global Deterioration Scale (GDS). Psychopharmacol Bull24, 661–663.
32.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
33.
MorrisJC (1997) Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr9 Suppl 1, 173–176; discussion 177-178.
34.
WallinA, EdmanA, BlennowK, GottfriesCG, KarlssonI, ReglandB, SjogrenM (1996) Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol9, 185–199.
35.
RoyallDR, MahurinRK, GrayKF (1992) Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc40, 1221–1226.
36.
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR, American Psychiatric Association, Washington, DC.
37.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
38.
ErkinjunttiT, InzitariD, PantoniL, WallinA, ScheltensP, RockwoodK, RomanGC, ChuiH, DesmondDW (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl59, 23–30.
39.
FazekasF, ChawlukJB, AlaviA, HurtigHI, ZimmermanRA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol149, 351–356.
40.
QuinlanP, HorvathA, NordlundA, WallinA, SvenssonJ (2017) Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia. Psychoneuroendocrinology86, 169–175.
41.
LoY, MendellNR, RubinDB (2001) Testing the number of components in a normal mixture. Biometrika88, 767–778.
42.
HensonJM, ReiseSP, KimKH (2007) Detecting mixtures from structural model differences using latent variable mixture modeling: a comparison of relative model fit statistics. Struct Equ Modeling, 14, 202–226.
43.
YangC (2006) Evaluating latent class analysis models in qualitative phenotype identification. Comput Stat Data Anal50, 1090–1104.
44.
AldridgeAA, RoeschSC (2008) Developing coping typologies of minority adolescents: a latent profile analysis. J Adolesc31, 499.
45.
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders DSM-5 (5th ed.), American Psychiatric Association, Arlington, VA.
